NCT06662279 Hyrax Vs. Invisalign Palatal Expander Clinical Study
| NCT ID | NCT06662279 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Align Technology, Inc. |
| Condition | Malocclusions |
| Study Type | INTERVENTIONAL |
| Enrollment | 36 participants |
| Start Date | 2024-10-25 |
| Primary Completion | 2025-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 36 participants in total. It began in 2024-10-25 with a primary completion date of 2025-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to compare expansion result and the overall experience between the Invisalign Palatal Expander and the Hyrax expander.
Eligibility Criteria
Inclusion Criteria: * Subject ages 6-11 years old * Subject must need maxillary expansion * Subjects must have erupted dentition in the area of the primary molars or permanent premolars and the first permanent molar Exclusion Criteria: * Subjects with palatal exostosis/surface aberration/ cleft palate * Subject's dentition not compatible with device or allergy to device materials * Subject with active caries, periodontal disease, TMD
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06662279 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 11 Years, studying Malocclusions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06662279 currently recruiting?
Yes, NCT06662279 is actively recruiting participants. Contact the research team at skaushik@aligntech.com for enrollment information.
Where is the NCT06662279 trial being conducted?
This trial is being conducted at Laguna Hills, United States, Warner Robins, United States, Naperville, United States, Chevy Chase, United States.
Who is sponsoring the NCT06662279 clinical trial?
NCT06662279 is sponsored by Align Technology, Inc.. The trial plans to enroll 36 participants.